Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation (vol 13, 993022, 2022)

被引：0

作者：

Liu, Minglu ^{[1
]}

Hu, Tong ^{[2
,3
]}

Gou, Wenfeng ^{[2
]}

Chang, Huajie ^{[2
]}

Li, Yanli ^{[2
]}

Li, Yiliang ^{[2
]}

Zuo, Daiying ^{[3
]}

Hou, Wenbin ^{[2
]}

Jiao, Shunchang ^{[1
]}

机构：

[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Med Oncol, Beijing, Peoples R China

[2] Peking Union Med Coll & Chinese Acad Med Sci, Inst Radiat Med, Tianjin Key Lab Radiat Med & Mol Nucl Med, Tianjin, Peoples R China

[3] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang, Peoples R China

来源：

关键词：

icaritin; nasopharyngeal carcinoma; ROS; senescence; network pharmacology;

D O I：

10.3389/fphar.2023.1140018

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页数：1